raloxifene hydrochloride has been researched along with Neurodegenerative Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Veenman, L | 1 |
| Casalena, G; Germain, D; Gomez, M; Jenkins, EC; Kenny, TC; Manfredi, G; Shah, N; Zhao, D | 1 |
| Bhowmik, M; Pottoo, FH; Vohora, D | 1 |
| Arevalo, MA; Azcoitia, I; Garcia-Segura, LM; Lagunas, N; Santos-Galindo, M | 1 |
| Doshida, M; Du, B; Igarashi, H; Kawagoe, J; Kurachi, H; Mori-Abe, A; Ohishi, A; Ohmichi, M; Ohshima, C; Ohta, T; Saitoh, M; Takahashi, K; Takahashi, T; Tezuka, N | 1 |
2 review(s) available for raloxifene hydrochloride and Neurodegenerative Diseases
| Article | Year |
|---|---|
Raloxifene as Treatment for Various Types of Brain Injuries and Neurodegenerative Diseases: A Good Start.
Topics: Animals; Brain Injuries; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2020 |
Selective estrogen receptor modulators as brain therapeutic agents.
Topics: Animals; Apoptosis; Brain; Brain Diseases; Brain Injuries; Encephalitis; Humans; Mood Disorders; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen | 2011 |
3 other study(ies) available for raloxifene hydrochloride and Neurodegenerative Diseases
| Article | Year |
|---|---|
Raloxifene is a Female-specific Proteostasis Therapeutic in the Spinal Cord.
Topics: Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Male; Mice; Neurodegenerative Diseases; Proteasome Endopeptidase Complex; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sex Characteristics; Spinal Cord; Ubiquitination | 2021 |
Raloxifene protects against seizures and neurodegeneration in a mouse model mimicking epilepsy in postmenopausal woman.
Topics: Animals; Bone Density; Cyclohexenes; Disease Models, Animal; Epilepsy, Temporal Lobe; Female; Hippocampus; Humans; Kainic Acid; Mice; Neurodegenerative Diseases; Neurons; Postmenopause; Raloxifene Hydrochloride; Seizures; Transforming Growth Factor beta3; Vinyl Compounds | 2014 |
Both estrogen and raloxifene protect against beta-amyloid-induced neurotoxicity in estrogen receptor alpha-transfected PC12 cells by activation of telomerase activity via Akt cascade.
Topics: Amyloid beta-Peptides; Blotting, Western; Brain; Cell Line, Tumor; Enzyme Activation; Estrogens; Humans; Neurodegenerative Diseases; Pheochromocytoma; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Raloxifene Hydrochloride; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; Selective Estrogen Receptor Modulators; Telomerase; Transfection | 2004 |